Ticker VICOListed on Nasdaq Stockholm
Vicore Pharma Holding AB
At a glance
Most recent filing on June 15, 2026 — an open-market purchase by peter guenter on Jun 12, 2026.
We hold 29 visible filings, going back to November 24, 2016.
Filings we could not classify with confidence are set aside for review, so they are in none of these counts.
Insider trades
What is a MAR filing?5 of 29 shown
- peter guenter Board member1,691,966 SEKOpen-market buy
- Ahmed Mousa Chief executive officer6,230 SEKOpen-market buy
- Ahmed Mousa Chief executive officer90,920 SEKOpen-market buy
- Johannes Schikan Chair of the board78,000 SEKOpen-market buy
- Johannes Schikan Chair of the board78,000 SEKOpen-market buy
Short positions
All short positionsNet short positions of 0.5% or more in Vicore Pharma Holding AB that are open today, as the regulator publishes them. Together they come to 1.80% of the shares. Positions below 0.5% are not published, so the real total can be higher.
2 open positions, together 1.80%. The holders and their history are part of the subscription.
Källa: Finansinspektionen, October 31, 2026.